» Articles » PMID: 24224789

Maternal Western Diet Primes Non-alcoholic Fatty Liver Disease in Adult Mouse Offspring

Overview
Specialty Physiology
Date 2013 Nov 15
PMID 24224789
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Metabolic programming via components of the maternal diet during gestation may play a role in the development of different aspects of the metabolic syndrome. Using a mouse model, we aimed to characterize the role of maternal western-type diet in the development of non-alcoholic fatty liver disease (NAFLD) in the offspring.

Methods: Female mice were fed either a western (W) or low-fat control (L) semisynthetic diet before and during gestation and lactation. At weaning, male offspring were assigned either the W or the L diet, generating four experimental groups: WW, WL, LW and LL offspring. Biochemical, histological and epigenetic indicators were investigated at 29 weeks of age.

Results: Male offspring exposed to prenatal and post-weaning western-style diet (WW) showed hepatomegaly combined with accumulation of hepatic cholesterol and triglycerides. This accumulation was associated with up-regulation of de novo lipid synthesis, inflammation and dysregulation of lipid storage. Elevated hepatic transaminases and increased expression of Tnfa, Cd11, Mcp1 and Tgfb underpin the severity of liver injury. Histopathological analysis revealed the presence of advanced steatohepatitis in WW offspring. In addition, alterations in DNA methylation in key metabolic genes (Ppara, Insig, and Fasn) were detected.

Conclusion: Maternal dietary fat intake during early development programmes susceptibility to liver disease in male offspring, mediated by disturbances in lipid metabolism and inflammatory response. Long-lasting epigenetic changes may underlie this dysregulation.

Citing Articles

Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT.

Kong L, He Q, Ma D, Shi W, Xin Q, Jiang C FEBS Open Bio. 2024; 14(5):831-842.

PMID: 38531630 PMC: 11073500. DOI: 10.1002/2211-5463.13797.


PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?.

Theys C, Lauwers D, Perez-Novo C, Vanden Berghe W Biomedicines. 2022; 10(12).

PMID: 36551797 PMC: 9775974. DOI: 10.3390/biomedicines10123041.


Maternal Fructose Intake, Programmed Mitochondrial Function and Predisposition to Adult Disease.

Smith E, Dyson R, Weth F, Berry M, Gray C Int J Mol Sci. 2022; 23(20).

PMID: 36293068 PMC: 9603452. DOI: 10.3390/ijms232012215.


Crossbred Sows Fed a Western Diet during Pre-Gestation, Gestation, Lactation, and Post-Lactation Periods Develop Signs of Lean Metabolic Syndrome That Are Partially Attenuated by Spirulina Supplementation.

Lugara R, Renner S, Wolf E, Liesegang A, Bruckmaier R, Giller K Nutrients. 2022; 14(17).

PMID: 36079836 PMC: 9460909. DOI: 10.3390/nu14173574.


Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring.

Wajsbrot N, Leite N, Salles G, Villela-Nogueira C World J Gastroenterol. 2022; 28(25):2890-2899.

PMID: 35978876 PMC: 9280730. DOI: 10.3748/wjg.v28.i25.2890.